Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma

NCT00387023 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin's Lymphoma
Lymphoma

Interventions

DRUG: Rituximab
DRUG: Zevalin

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]